CFO appointment
SecureTech Innovations, Inc. appoints Anthony Vang as CFO
SecureTech Innovations, Inc. reported in a Form 8-K filed June 10, 2026 that Anthony Vang was appointed Chief Financial Officer, effective June 5, 2026.
In the filing's words
On June 5, 2026, the Board of Directors (“ Board ”) of SecureTech Innovations, Inc. (“ SecureTech ” or “ Company ”) appointed Anthony Vang as the Company’s full-time Chief Financial Officer (“ CFO ”), effective as of that date.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | SecureTech Innovations, Inc. (SCTH) |
|---|---|
| Event | Appointment |
| Incoming | Anthony Vang |
| Title in the filing | Chief Financial Officer |
| Effective | June 5, 2026 |
| 8-K filed | June 10, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Secretary, Treasurer, and Principal Financial Officer, SecureTech Innovations, Inc. |
| SEC CIK | 0001703157 |
SecureTech Innovations, Inc. reported this change in a Form 8-K, Item 5.02, filed June 10, 2026. The filing's own words are quoted above.
Other records naming Anthony Vang
1The incoming officer on this record, matched by name. Career line.
2026-03-25 · 10-K signature
Anthony Vang signed Securetech Innovations, Inc.'s annual report as Secretary, Treasurer, Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, and Director
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Anthony Vang? Send a correction with the primary source.